Margins of education segment of Q2FY25 looks lowest in last 8 quarters. Can someone help how to read this?
Education has seasonality, Revenues depend upon admission season.
As per the below snippet from AR, company recognize registration fee on the commencement of semester & course fee on straight line basis (& hence creation of contract liabilities).
Even if we assume some seasonality (and after considering below text on website), Q1 should have higher margins, which is not the case. In my view, H1 margins is the sustainable level of margins and last year was the one-off for some reason, in which case normalization of it will take 2 quarters, which would lead to slower YoY growth in H2
Have read last few years AR and understood that higher revenue and margins in education segment in Q3FY24 & Q4FY24 were probably because there were delays in starting the first batch of 3rd / 4th & 5th year of UG and hence that period had seen overlapping in bookings of few of those batches, which should normalize in next 2 quarters this year. If that’s true, believe Q3FY25 should be flattish quarter YoY. However, there’s some triggers on medium term that will drive growth:
Q4FY25
- As per discussion in AGM, Company is opening up 2,00,000 sq ft building in New OP block in Jan 2025. Reading this with latest AR, I believe this is for neuroscience. No details regarding the bed capacity is provided. Conservatively assuming 150 beds @ 30000 ARPOB and 50% occupancy, this should contribute 80cr annually to revenue. Bed capacity could be higher and of course, if the building is for neuroscience, it could have much higher ARPOB then this estimate
FY26
- This would be first full year of absorbing KMCH institute passed out graduates, this would bring in some efficiencies in employee cost
- As per AR, institute will be starting its first PG batch in FY26. Again just assuming conservatively 30 seats and fees in line with current UG batches, it should contribute 3cr to revenue (usually fees of PGs are atleast 2x the UG batches).
- Company will also add new 100 beds in the space in main center, which got available from shifting hostels and some educational sections in new Neelambur campus. Taking 50% occupancy and ARPOB of 30000, it should contribute ~55cr annually to revenue
FY27
- Will add 2nd batch of PG (with same assumptions as above, it should contribute 3cr to revenue)
- 300 bed Chennai hospital to become operational. Assuming 40000 ARPOB and 40% occupancy in 1st year, it should contribute 175cr to revenue
FY28
- 3rd batch of PG (~3cr of revenue)
- Assuming chennai hospital occupancy reaches 60% and 40000 ARPOB, it should add 88cr to revenue
Net debt
Company had net debt of 131cr at september end. Company would do CAPEX of 300cr for Chennai hospital and assuming would further require 150cr for completing the new building & additional beds in main center and above assumptions hold true, company would be debt free by the end of FY26 & hence savings in interest cost from FY27 onwards. However, to sustain the growth momentum, company would need to announce additional CAPEX in FY26. In AGM, mangement did mentioned that they are evaluating options to setup windmill
Insiderbuying
Promoter is regularly buying from open market every quarter (recently bought few shares this week too), albeit in small quantity, but shows management is positive about the near term / mid term future
Chairman’s speech of AGM 2024: https://www.kmchhospitals.com/wp-content/uploads/2024/08/Chairman-Speech-English.pdf
Hey,
Very insightful estimates. Can you please provide the basis or sources also? Has company mentioned anywhere that Chennai facility will be operational by FY27?
I think this was communicated in AGM, you can find this in Vijay’s post of Aug 2024
Healthcare sector related updates from Budget 2025
Source - x.com